Oncology

Showing 433–456 of 488 results

Thalix 100 mg Capsule

Molecule : ThalidomideManufacturer : Fresenius Kabi India Private Limited
Thalix 100mg Capsules are manufactured by Fresenius Kabi India Pvt Ltd in India and contain 100mg of Thalidomide per capsule.

Thalix 50 mg Capsule

Molecule : ThalidomideManufacturer : Fresenius Kabi India Private Limited
Thalix 50mg Capsules are manufactured by Fresenius Kabi India Pvt Ltd in India and contain 50mg of Thalidomide per capsule.

Tibsovo 250 mg Tablet

Molecule : IvosidenibManufacturer : Servier
Tibsovo 250 mg is an oral, targeted cancer therapy that contains ivosidenib, a first-in-class IDH1 inhibitor. This medication is designed

Tipanat Tablet

Molecule : TipiracilManufacturer : Natco Pharma

Tivoxen 1.34 mg Capsule

Molecule : TivozanibManufacturer : Everest Pharma
Tivoxen Capsule contains Tivozanib, a targeted anti-cancer medicine used for the treatment of advanced renal cell carcinoma (RCC), a type

Tofaxen 5 mg Tablet

Molecule : TofacitinibManufacturer : Everest Pharma

Tractoni 100 mg Capsule

Molecule : LarotrectinibManufacturer : Ziska Pharmaceuticals Ltd

Trifluxen Tablet

Molecule : TipiracilManufacturer : Everest Pharma

Trikafta Tablet

Molecule : ElexacaftorManufacturer : Vertex Pharmaceuticals

Trodelvy 180 mg Vial

Molecule : Sacituzumab GovitecanManufacturer : Gilead
Trodelvy 180 mg Vial contains Sacituzumab Govitecan, an advanced targeted cancer therapy classified as an antibody-drug conjugate (ADC). It is

Trombonat 25 mg Tablet

Molecule : EltrombopagManufacturer : Natco Pharma

Trombonat 50 mg Tablet

Molecule : EltrombopagManufacturer : Natco Pharma

Truqap 200 mg Tablet

Molecule : CapivasertibManufacturer : Astrazeneca

Tucanat 150 mg Tablet

Molecule : TucatinibManufacturer : Natco Pharma

Tucaxen 150 mg Tablet

Molecule : TucatinibManufacturer : Everest Pharma

Tukysa 150 mg Tablet

Molecule : TucatinibManufacturer : Seagen
(1)
TUKYSA® (tucatinib) is an FDA-approved oral medication used to treat adults with certain types of HER2-positive metastatic breast cancer and HER2-positive, RAS wild-type metastatic colorectal cancer. It is a tyrosine kinase inhibitor (TKI) that targets HER2 protein signaling inside cancer cells, offering patients a well-tolerated and effective non-chemotherapy option — including those with brain metastases.

Tykerb 250 mg Tablet

Molecule : LapatinibManufacturer : Novartis
Tykerb 250 mg Tablets are manufactured by NOVARTIS INDIA LTD in United Kingdom and contain 250 mg of Lapatinib per

Ultragef Ip 250 mg Tablet

Molecule : GefitinibManufacturer : Bangalore Pharmaceutical Amp Research Laboratory Private Limited
UltraGef Gefitinib IP 250 mg Tablets are manufactured by BPRL in India and contain 250 mg of Gefitinib per tablet.

Veenat 100 mg Capsule

Molecule : ImatinibManufacturer : Natco Pharma

Veenat 400 mg Tablet

Molecule : ImatinibManufacturer : Natco Pharma
Veenat 400 mg Tablets are manufactured by Natco Pharma Ltd in India and contain 400mg of Imatinib per tablet. Each

Venclexta 100 mg Tablet

Molecule : VenetoclaxManufacturer : Abbvie

Ventax 100 mg Tablet

Molecule : VenetoclaxManufacturer : Ziska Pharmaceuticals Ltd

Ventoxen 10 mg Tablet

Molecule : VenetoclaxManufacturer : Everest Pharma